| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 3843317 | Actas Urológicas Españolas | 2014 | 9 Pages |
Abstract
The prevention and management of bone involvement in patients with prostate cancer is critical to quality of life in these patients and requires an individualized approach. Before starting a prolonged androgen deprivation, baseline risk of fracture should be evaluated in order to adopt the proper protective measures. In patients with metastases, early treatments reducing the risk of bone events should be taken into account.
Related Topics
Health Sciences
Medicine and Dentistry
Nephrology
Authors
B. Miñana, J.M. Cózar, A. Alcaraz, J. Morote, F.J. Gómez-Veiga, E. Solsona, A. RodrÃguez-AntolÃn, J. Carballido,